FibroGen (FGEN) Tops Q4 EPS by 2c

FibroGen (NASDAQ: FGEN) reported Q4 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $42.5 million versus the consensus estimate of $49.77 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance